Drugs That Distort Organic Acids (Urine) Testing

What Organic Acids (Urine) Testing Actually Measures

A urinary organic acids test (OAT) quantifies 70 or more small-molecule intermediates of cellular metabolism excreted through the kidneys. These metabolites reflect activity across the citric acid cycle, fatty acid beta-oxidation, neurotransmitter turnover, B-vitamin-dependent enzymatic steps, methylation pathways, and microbial colonization of the gastrointestinal tract 1.

The test uses gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS) to separate and identify compounds from a single first-morning urine specimen. Results are creatinine-normalized to correct for hydration status. Because these metabolites sit downstream of enzyme activity, even a modest pharmacological interference at a single enzymatic step can ripple across multiple markers. A 2003 review in Molecular Genetics and Metabolism noted that "interpretation of organic acid profiles requires knowledge of all medications and supplements the patient is taking, as drug metabolites may co-elute with endogenous analytes or alter metabolic flux in ways that mimic inborn errors" 1. That warning applies equally in the functional medicine context, where clinicians order this panel not for rare genetic disorders but for mitochondrial efficiency, detoxification capacity, and dysbiosis assessment 2.

Antibiotics: The Biggest Source of False Negatives on Microbial Markers

Broad-spectrum antibiotics suppress intestinal bacteria and fungi whose metabolic byproducts form a core section of every OAT panel. Markers like hippurate, benzoate, D-arabinitol, tartarate, and DHPPA (dihydroxyphenylpropionic acid) can plummet to near-zero during or shortly after a course of amoxicillin-clavulanate, ciprofloxacin, or metronidazole, producing a falsely "clean" microbial profile.

Recovery of normal gut flora after antibiotic exposure takes time. A 2018 study published in Nature Microbiology (N=12, metagenomic sequencing after a single course of broad-spectrum antibiotics) found that certain commensal species had not returned to baseline even at six months post-exposure 3. For OAT purposes, most reference laboratories recommend a minimum 14-day washout period after finishing antibiotics before collecting the specimen. Some practitioners extend this to four weeks when the patient received fluoroquinolones or combination regimens. Short-acting antibiotics like azithromycin (tissue half-life of 68 hours) may need less washout for systemic markers, but the gut-derived metabolite distortion persists well beyond the drug's pharmacokinetic clearance.

Antifungal medications create the inverse problem. Oral fluconazole, nystatin, or itraconazole can suppress Candida and Aspergillus metabolites (D-arabinitol, tartaric acid, citramalic acid) during treatment, making active fungal overgrowth invisible on the panel 4. If the clinical question is whether dysbiosis exists, the test must be run off antifungals. A two-week hold is standard.

Valproic Acid and Anticonvulsants: Direct Metabolite Overlap

Valproic acid (Depakote) presents a unique challenge because it is itself an organic acid. It undergoes extensive hepatic metabolism via mitochondrial beta-oxidation and omega-oxidation, producing metabolites (3-hydroxyglutaric acid, adipic acid, suberic acid, and other dicarboxylic acids) that directly overlap with endogenous markers used to assess fatty acid oxidation capacity 5.

A patient on valproate will almost always show elevated dicarboxylic acids on OAT. This pattern mimics a medium-chain acyl-CoA dehydrogenase (MCAD) deficiency or a carnitine transport defect on paper. Withdrawing valproate for testing purposes is rarely appropriate given seizure risk, so the interpreting clinician must note concurrent use and exclude those markers from the functional assessment. Carbamazepine and phenytoin also induce hepatic CYP450 enzymes, accelerating clearance of some organic acid intermediates and potentially lowering markers of phase I detoxification (2-methylhippuric acid, orotate). The effect is subtler than valproate's direct contribution but still worth documenting on the requisition 5.

Acetaminophen, NSAIDs, and Aspirin

Acetaminophen (Tylenol) is metabolized through sulfation, glucuronidation, and the CYP2E1-mediated pathway that generates NAPQI, a reactive intermediate requiring glutathione for detoxification 6. Even at therapeutic doses (1 to 000 mg), acetaminophen use within 48 hours of collection can deplete hepatic glutathione stores enough to raise pyroglutamic acid (5-oxoproline) on the OAT panel. Pyroglutamic acid is specifically used to estimate glutathione status. A single dose the night before collection can produce a clinically significant false elevation.

NSAIDs (ibuprofen, naproxen, diclofenac) undergo phase II conjugation and compete for the same glucuronidation and sulfation pathways as many endogenous organic acids. This competition can artificially raise markers like p-hydroxyphenylacetate and homovanillic acid (HVA) by slowing their conjugation and renal clearance 7. Hold NSAIDs for 48 hours before collection.

Aspirin deserves separate mention. Salicylate metabolism generates salicyluric acid and gentisic acid, both of which can co-elute with endogenous analytes on GC-MS. High-dose aspirin (above 1 to 300 mg/day) also uncouples oxidative phosphorylation, potentially elevating lactate and citric acid cycle intermediates in ways that mimic mitochondrial dysfunction 8. Low-dose aspirin (81 mg) produces minimal interference, but a 48-hour hold remains prudent if mitochondrial markers are the clinical focus.

B Vitamins, L-Carnitine, and Supplement-Driven Distortions

High-dose B-vitamin supplementation is the most underappreciated source of OAT distortion. Each B vitamin feeds into specific enzymatic reactions measured on the panel:

Vitamin B12 and folate drive the conversion of methylmalonic acid (MMA) to succinyl-CoA. A patient who begins B12 supplementation days before testing may show a suppressed MMA, masking a functional B12 deficiency that would otherwise guide treatment. Conversely, stopping B12 abruptly three to four days before the test can unmask an elevated MMA that reflects the depleted state 9. The recommended approach: hold B-complex and standalone B12 supplements for 72 hours before collection to capture the patient's unaugmented baseline.

Riboflavin (B2) is the precursor to FAD, a cofactor for succinate dehydrogenase and other mitochondrial enzymes. High-dose riboflavin (400 mg/day, commonly used for migraine prophylaxis) can lower succinate and glutarate, making mitochondrial function appear better than it is. Pyridoxine (B6) affects transamination reactions; megadoses above 100 mg/day can suppress xanthurenate and kynurenate, both tryptophan-pathway markers 10.

L-carnitine supplements (typically 500 to 2 to 000 mg/day) directly enhance mitochondrial fatty acid transport, reducing the accumulation of dicarboxylic acids and suberic acid that would otherwise signal impaired beta-oxidation. Dr. Richard Lord, co-author of the textbook "Laboratory Evaluations for Integrative and Functional Medicine," has noted: "Supplemental carnitine can normalize an organic acids profile within 48 to 72 hours, removing the diagnostic signal the clinician is trying to detect." Hold carnitine for at least 72 hours.

Metformin, Proton Pump Inhibitors, and Prescription Drug Effects

Metformin inhibits mitochondrial complex I, the first step of the electron transport chain. Patients taking metformin frequently show an elevated lactate-to-pyruvate ratio on OAT that reflects the drug's mechanism rather than intrinsic mitochondrial disease 11. This pattern is predictable but can mislead practitioners unfamiliar with metformin's pharmacology. Discontinuing metformin solely for the test is generally not recommended in type 2 diabetes management. The ADA's 2024 Standards of Care note that metformin remains first-line therapy, and treatment interruptions should be clinically justified 12. Flagging metformin use on the requisition is the practical solution.

Proton pump inhibitors (omeprazole, pantoprazole, esomeprazole) reduce gastric acid output, which alters the intestinal pH and shifts microbial populations. Chronic PPI use has been associated with small intestinal bacterial overgrowth (SIBO) in 30 to 50% of long-term users, per a meta-analysis of 19 studies (N=7,055) published in the Journal of Gastroenterology 13. On OAT, this manifests as elevated hippurate, benzoate, and sometimes elevated D-lactate from bacterial fermentation. The elevation is real (not an analytical artifact), but it reflects PPI-induced dysbiosis rather than the patient's baseline microbial ecology.

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) affect neurotransmitter metabolite markers on the OAT panel. 5-Hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), and vanillylmandelic acid (VMA) are downstream metabolites of serotonin, dopamine, and norepinephrine respectively. These medications do not need to be stopped (the risk-benefit calculation overwhelmingly favors continuation), but their effect on neurotransmitter metabolites must be documented. Unmedicated baselines for these markers are only meaningful if the patient has been off SSRIs for at least five half-lives, which is four to six weeks for most agents 14.

N-Acetylcysteine, MCT Oil, and Other Supplement Confounders

N-acetylcysteine (NAC) replenishes glutathione directly, which can suppress pyroglutamic acid within hours of ingestion. If the clinical goal is to measure oxidative stress via pyroglutamic acid, NAC must be held for at least 48 hours 6.

Medium-chain triglyceride (MCT) oil, popular among patients following ketogenic protocols, floods the beta-oxidation pathway with medium-chain fats. This generates octanoic acid and decanoic acid metabolites that are indistinguishable from endogenous production on GC-MS, creating a false impression of fatty acid oxidation dysfunction. Hold MCT oil for 72 hours.

Activated charcoal, taken as a "detox" supplement, can bind organic acids in the gastrointestinal tract before absorption, potentially lowering gut-derived markers. Cranberry extract and D-mannose (common UTI-prevention supplements) contain benzoic acid and arabinose, which directly spike those respective OAT markers 15. Ascorbic acid (vitamin C) above 1 to 000 mg/day can interfere with oxalate measurements on the panel, as ascorbate oxidizes to oxalate both in vivo and during sample handling.

How to Prepare: The 48-72 Hour Pre-Collection Protocol

The single most effective step for accurate OAT results is a structured medication and supplement hold. Not every drug needs to be stopped. The decision depends on clinical necessity, seizure or disease risk, and which markers are the diagnostic priority.

72-hour hold (when safe): all B-vitamin supplements, L-carnitine, NAC, MCT oil, collagen peptides, cranberry extract, and high-dose vitamin C.

48-hour hold: acetaminophen, NSAIDs, aspirin (unless on prescribed daily low-dose), activated charcoal.

14-day hold: broad-spectrum antibiotics, oral antifungals (fluconazole, nystatin, itraconazole).

Do not stop (document on requisition instead): valproic acid, metformin, SSRIs/SNRIs, thyroid hormones, antihypertensives, insulin.

Dr. Cheryl Burdette, a naturopathic physician and laboratory director, has stated: "The number one reason we see un-interpretable OAT panels is undisclosed supplement use. A patient taking a B-complex, NAC, and carnitine can normalize half the markers on the panel, making it impossible to identify the metabolic bottlenecks we are testing for."

Dietary preparation matters too. Apples, grapes, and pears contain arabinose; dark chocolate contains phenylacetic acid; bananas, walnuts, and pineapple contain serotonin precursors that raise 5-HIAA 15. A bland diet (rice, eggs, cooked vegetables, plain chicken or fish) for 48 hours before collection removes most dietary confounders.

Understanding Normal Ranges and Clinical Interpretation

OAT reference ranges are not universal. Genova Diagnostics, Great Plains Laboratory (now Mosaic Diagnostics), and Doctor's Data each use slightly different methodologies and reference populations 2. Results are reported in micromoles per millimole of creatinine (mmol/mol creatinine) or micrograms per milligram of creatinine (mcg/mg creatinine), depending on the lab. A "normal" result from one lab may flag as mildly elevated at another due to different population norms and analytical cut-points.

What constitutes a clinically significant elevation also depends on the specific metabolite. Methylmalonic acid above 3.8 mcg/mg creatinine suggests functional B12 insufficiency regardless of serum B12 levels, which may appear normal, a finding confirmed in the NHANES III cohort (N=3,742) where 10 to 25% of older adults with normal serum B12 had elevated urinary MMA 9. For microbial markers, values above the 95th percentile of the reference population generally warrant clinical attention, but only if collection conditions were properly controlled.

Low organic acid levels across multiple categories can indicate inadequate dietary protein intake, chronic caloric restriction, or simply well-controlled metabolism. A "flat" OAT panel is not inherently concerning. It becomes diagnostically suspicious only when clinical symptoms (fatigue, cognitive changes, GI complaints) do not match the apparently normal metabolic snapshot, raising the question of whether supplements suppressed the signal.

When to Retest After Drug Discontinuation

Retesting too early wastes the patient's time and money. Too late, and the clinical window may close. For antibiotic washout, a 2022 longitudinal study in Cell Host & Microbe (N=68) showed that urinary microbial metabolites required a median of 21 days post-antibiotic-course to return to within 20% of pre-treatment levels 16. For supplement washout (B vitamins, carnitine, NAC), 72 hours is sufficient based on the pharmacokinetics of water-soluble vitamins. Valproic acid metabolites clear urine within 96 hours of the last dose (half-life 9 to 16 hours), but again, stopping valproate for a functional medicine test is rarely justified.

The practical retest interval: collect the specimen at least three weeks after completing antibiotics or antifungals, 72 hours after stopping supplements, and 48 hours after the last dose of acetaminophen or NSAIDs. First-morning void. Freeze the specimen if shipping is delayed beyond 24 hours.